Gabelli Funds’s Dr. Reddy's Laboratories RDY Stock Holding History

Gabelli Funds’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-95,000	Closed	-$1.21M	–	1153
2015 Q3	$1.21M	Buy	95,000 +12,500	+15%	+$155K	0.01%	820
2015 Q2	$913K	Sell	82,500 -15,000	-15%	-$166K	﹤0.01%	888
2015 Q1	$1.11M	Buy	97,500 +5,000	+5%	+$53K	0.01%	859
2014 Q4	$933K	Hold	92,500	–	–	﹤0.01%	890
2014 Q3	$972K	Buy	92,500 +10,000	+12%	+$94K	﹤0.01%	895
2014 Q2	$712K	Buy	+82,500	New	+$694K	﹤0.01%	928

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gabelli Funds's RDY Position: Q4 2015 in Review

Gabelli Funds sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 95,000 shares — an estimated $1.21M sold.

Gabelli Funds first reported a position in RDY in Q2 2014 and held it in 6 quarters. The position peaked at $1.21M in Q3 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

Gabelli Funds reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
Gabelli Funds sold 95,000 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $1.21M.
Gabelli Funds first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 6 quarters.
Gabelli Funds's Dr. Reddy's Laboratories position peaked at $1.21M in Q3 2015.
174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Gabelli Funds's 13F filing for Q4 2015, filed 5 Feb 2016.